207 related articles for article (PubMed ID: 38233524)
1. Autoreactive T cells target peripheral nerves in Guillain-Barré syndrome.
Súkeníková L; Mallone A; Schreiner B; Ripellino P; Nilsson J; Stoffel M; Ulbrich SE; Sallusto F; Latorre D
Nature; 2024 Feb; 626(7997):160-168. PubMed ID: 38233524
[TBL] [Abstract][Full Text] [Related]
2. Effector/memory CD8
Yang M; Shi XQ; Peyret C; Oladiran O; Wu S; Chambon J; Fournier S; Zhang J
Brain Behav Immun; 2018 Jul; 71():142-157. PubMed ID: 29627532
[TBL] [Abstract][Full Text] [Related]
3. Differential distribution of HLA-DQ beta/DR beta epitopes in the two forms of Guillain-Barré syndrome, acute motor axonal neuropathy and acute inflammatory demyelinating polyneuropathy (AIDP): identification of DQ beta epitopes associated with susceptibility to and protection from AIDP.
Magira EE; Papaioakim M; Nachamkin I; Asbury AK; Li CY; Ho TW; Griffin JW; McKhann GM; Monos DS
J Immunol; 2003 Mar; 170(6):3074-80. PubMed ID: 12626563
[TBL] [Abstract][Full Text] [Related]
4. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
[TBL] [Abstract][Full Text] [Related]
5. Th1/Th2/Th17/Treg cytokines in Guillain-Barré syndrome and experimental autoimmune neuritis.
Zhang HL; Zheng XY; Zhu J
Cytokine Growth Factor Rev; 2013 Oct; 24(5):443-53. PubMed ID: 23791985
[TBL] [Abstract][Full Text] [Related]
6. Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain-Barré syndrome.
Yako K; Kusunoki S; Kanazawa I
J Neurol Sci; 1999 Oct; 168(2):85-9. PubMed ID: 10526188
[TBL] [Abstract][Full Text] [Related]
7. A novel myelin P0-specific T cell receptor transgenic mouse develops a fulminant autoimmune peripheral neuropathy.
Louvet C; Kabre BG; Davini DW; Martinier N; Su MA; DeVoss JJ; Rosenthal WL; Anderson MS; Bour-Jordan H; Bluestone JA
J Exp Med; 2009 Mar; 206(3):507-14. PubMed ID: 19221395
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of activated T-cells and reduced levels of CD4/CD25+ cells in peripheral blood of Guillain-Barré syndrome patients compared to controls.
Harness J; McCombe PA
J Clin Neurosci; 2008 Sep; 15(9):1031-5. PubMed ID: 18653346
[TBL] [Abstract][Full Text] [Related]
9. Integrative molecular profiling of autoreactive CD4 T cells in autoimmune hepatitis.
Renand A; Cervera-Marzal I; Gil L; Dong C; Garcia A; Kervagoret E; Aublé H; Habes S; Chevalier C; Vavasseur F; Clémenceau B; Cardon A; Judor JP; Mosnier JF; Tanné F; Laplaud DA; Brouard S; Gournay J; Milpied P; Conchon S
J Hepatol; 2020 Dec; 73(6):1379-1390. PubMed ID: 32649971
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal anti-alphaB-crystallin IgG antibody responses: potential inflammatory markers in Guillain-Barré syndrome.
Wanschitz J; Ehling R; Löscher WN; Künz B; Deisenhammer F; Kuhle J; Budka H; Reindl M; Berger T
J Neurol; 2008 Jun; 255(6):917-24. PubMed ID: 18712293
[TBL] [Abstract][Full Text] [Related]
11. Neutralizing antibodies to IL-18 ameliorate experimental autoimmune neuritis by counter-regulation of autoreactive Th1 responses to peripheral myelin antigen.
Yu S; Chen Z; Mix E; Zhu SW; Winblad B; Ljunggren HG; Zhu J
J Neuropathol Exp Neurol; 2002 Jul; 61(7):614-22. PubMed ID: 12125740
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Press R; Nennesmo I; Kouwenhoven M; Huang YM; Link H; Pashenkov M
J Neuroimmunol; 2005 Feb; 159(1-2):165-76. PubMed ID: 15652416
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal analysis of T-cell receptor repertoires reveals persistence of antigen-driven CD4
Servaas NH; Zaaraoui-Boutahar F; Wichers CGK; Ottria A; Chouri E; Affandi AJ; Silva-Cardoso S; van der Kroef M; Carvalheiro T; van Wijk F; Radstake TRDJ; Andeweg AC; Pandit A
J Autoimmun; 2021 Feb; 117():102574. PubMed ID: 33307312
[TBL] [Abstract][Full Text] [Related]
14. The critical role of IL-12p40 in initiating, enhancing, and perpetuating pathogenic events in murine experimental autoimmune neuritis.
Bao L; Lindgren JU; van der Meide P; Zhu Sw; Ljunggren HG; Zhu J
Brain Pathol; 2002 Oct; 12(4):420-9. PubMed ID: 12408228
[TBL] [Abstract][Full Text] [Related]
15. Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barré syndrome.
Wanschitz J; Maier H; Lassmann H; Budka H; Berger T
Brain; 2003 Sep; 126(Pt 9):2034-42. PubMed ID: 12847075
[TBL] [Abstract][Full Text] [Related]
16. [Autoantibodies in Guillain-Barré Syndrome].
Uchibori A; Chiba A
Brain Nerve; 2015 Nov; 67(11):1347-57. PubMed ID: 26560950
[TBL] [Abstract][Full Text] [Related]
17. Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides.
Tsuchida T; Parker KC; Turner RV; McFarland HF; Coligan JE; Biddison WE
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10859-63. PubMed ID: 7526383
[TBL] [Abstract][Full Text] [Related]
18. Lipooligosaccharide of Campylobacter jejuni prevents myelin-specific enteral tolerance to autoimmune neuritis--a potential mechanism in Guillain-Barre syndrome?
Jung S; Zimmer S; Lüneberg E; Frosch M; Karch H; Korn T; Toyka KV
Neurosci Lett; 2005 Jun 10-17; 381(1-2):175-8. PubMed ID: 15882812
[TBL] [Abstract][Full Text] [Related]
19. Guillain-Barré syndrome: epidemiology, pathophysiology and management.
Kuwabara S
Drugs; 2004; 64(6):597-610. PubMed ID: 15018590
[TBL] [Abstract][Full Text] [Related]
20. Thymic epithelium determines a spontaneous chronic neuritis in Icam1(tm1Jcgr)NOD mice.
Meyer zu Horste G; Mausberg AK; Cordes S; El-Haddad H; Partke HJ; Leussink VI; Roden M; Martin S; Steinman L; Hartung HP; Kieseier BC
J Immunol; 2014 Sep; 193(6):2678-90. PubMed ID: 25108020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
